In the current study, we demonstrate that BCL-2 expression in T cells of CLL patients is associated with immunosuppressive TME by promotion of Treg abundance and cytotoxic T lymphocyte (CTL) exhaustion. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.